Search Results 71-80 of 21134 for B cell lymphomas

  1. DNA Sequencing-Based Monitoring Of Minimal Residual Disease To Predict Relapse In Aggressive B-cell Non-Hodgkin Lymphomas - Mayo Clinic

    DNA Sequencing-Based Monitoring Of Minimal Residual Disease To Predict Relapse In Aggressive B-cell Non-Hodgkin Lymphomas · Share · Facebook · Twitter.

  2. Doctors and departments - Mayo Clinic

    Research. Mayo Clinic doctors and researchers are studying primary mediastinal large B-cell lymphoma (PMBCL) to look for new ways to improve diagnosis and ...

  3. CAR-T cell therapy - Mayo Clinic

    Lymphomas are cancers that affect white blood cells in the lymphatic system — a network of organs, glands, vessels and clusters of cells called lymph nodes. B- ...

  4. Non-Hodgkin lymphoma - Stages - Mayo Clinic

    B-cell lymphomas. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1480. Accessed Aug. 30, 2024. T ...

  5. A Study Of Copanlisib And Nivolumab In Treating Participants With Recurrent Or Refractory Diffuse Large B-cell Lymphoma Or Primary Mediastinal Large B-cell Lymphoma - Mayo Clinic

    A Study Of Copanlisib And Nivolumab In Treating Participants With Recurrent Or Refractory Diffuse Large B-cell Lymphoma Or Primary Mediastinal Large B-cell ...

  6. Non Hodgkin Clinical Trials

    ... B-cell lymphomas. Clinically, four weekly doses of rituximab have proven to be well tolerated and effective in previously untreated as well as relapsed ...

  7. A Phase 1/​2 Study Of STP938 For Adult Subjects With Relapsed/​Refractory B-Cell And T-Cell Lymphomas - Mayo Clinic

    The purpose of this study is to evaluate the safety and tolerability of STP938 as a single agent in adult subjects with R/R B-cell and T-cell lymphomas.

  8. Small lymphocytic lymphoma - Diagnosis and treatment - Mayo Clinic

    A complete blood count may be used to count the number of lymphocytes in a blood sample. A high number of B cells, one type of lymphocyte, could mean small ...

  9. Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma - Mayo Clinic

    Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma. Participation eligibility. Participant ...

  10. A Study Evaluating The Effectiveness Of Axicabtagene Ciloleucel Compared To Standard Of Care Therapy In Subjects With Relapsed/Refractory Diffuse Large B Cell Lymphoma - Mayo Clinic

    Histologically proven large B-cell lymphoma including the following types defined by WHO 2016 (Swerdlow et al, 2016): · Relapsed or refractory disease after ...